SiSaf was founded by Dr Suzanne Roghieh Saffie-Siebert in 2006 with the aim to research and develop her innovative drug delivery technology and to apply it to a wide range of dermatological products.

SiSaf is a venture-backed company, partnered to some of the UK’s leading Universities.

Our mission is to use our novel drug delivery technology to overcome the shortcomings of current skin care and skin treatment products.

Our technology is a bioactive delivery system that offers numerous advantages over existing dermatological delivery systems:

• It is non-toxic, non-irritating, and biodegradable.
• It is easy and cheap to manufacture.
• It increases stability of unstable compounds, such as biological actives.
• It enhances bioavailability - unlike any other delivery system on the market, SiSaf’s technology enhances the bioavailability of hydrophobic compounds.